Resmed Inc (RMD) Operating Margin (2009 - 2026)

Resmed (RMD) has reported Operating Margin for 18 consecutive years, with 30.66% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Margin fell 306.0% year-over-year to 30.66%; the trailing twelve-month figure through Jun 2026 stood at 33.37% (up 62.0% YoY), and the FY2026 full-year result was 33.37%, up 62.0% from the prior year.
• Operating Margin retreated to 30.66% in Q2 2026 per RMD's latest filing, from 34.92% in the prior quarter.
• Across five years, Operating Margin topped out at 34.92% in Q1 2026 and bottomed at 23.66% in Q4 2023.
• Historically, Operating Margin has averaged 29.97% across 5 years, with a median of 30.91% in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Margin tumbled 345 bps in 2023, then jumped 889 bps in 2024.
• Over 5 years, Operating Margin stood at 27.1% in 2022, then fell by 13 bps to 23.66% in 2023, then surged by 38 bps to 32.54% in 2024, then grew by 6 bps to 34.56% in 2025, then decreased by 11 bps to 30.66% in 2026.
• According to Business Quant data, Operating Margin over the past three periods registered 30.66%, 34.92%, and 34.56% for Q2 2026, Q1 2026, and Q4 2025 respectively.